Company: ABBV
Filing Date: 2025-02-14
Form Type: 10-K
Source: 0001551152-25-000020
Chunk: 281

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: 10-K
Item: Item 7
Chunk 281
---
— >100.0 %>100.0 %>100.0 %>100.0 %Total$658 $408 $158 61.3 %>100.0 %61.3 %>100.0 %

39     |  2024 Form 10-K

Percent changeAt actual currency ratesAt constant currency ratesyears ended December 31 (dollars in millions)2024202320222024202320242023Other NeuroscienceUnited States$224 $254 $456 (11.6)%(44.4)%(11.6)%(44.4)%International114 22 19 >100.0 %20.2 %>100.0 %24.4 %Total$338 $276 $475 22.4 %(41.9)%22.7 %(41.7)%Eye CareOzurdexUnited States$138 $143 $139 (4.1)%2.7 %(4.1)%2.7 %International356 329 289 8.3 %14.0 %10.7 %15.9 %Total$494 $472 $428 4.5 %10.3 %6.2 %11.6 %Lumigan/GanfortUnited States$187 $173 $242 7.5 %(28.4)%7.5 %(28.4)%International242 259 272 (6.4)%(4.8)%(3.9)%(3.6)%Total$429 $432 $514 (0.9)%(15.9)%0.6 %(15.3)%Alphagan/CombiganUnited States$95 $121 $202 (21.8)%(40.1)%(21.8)%(40.1)%International153 151 144 1.5 %4.9 %7.6 %10.4 %Total$248 $272 $346 (8.8)%(21.4)%(5.4)%(19.1)%RestasisUnited States$172 $382 $621 (55.2)%(38.5)%(55.2)%(38.5)%International52 54 45 (3.0)%19.3 %2.1